Signs of Addiction: A Clinician’s Complete Guide to the Physical, Behavioural, Emotional, and Social Signs of Substance Use Disorder and When to Get Help

How to recognise the signs of addiction across different substances, the DSM-5 criteria that define substance use disorder, the physical signs that family members can observe, the behavioural changes that often precede physical signs, the emotional and cognitive symptoms that develop over time, the impact on relationships and work, and what to do if you recognise the signs in yourself or in a loved one.

Clinically reviewed by Dr. Ponlawat Pitsuwan, Physician and Addiction Medicine Specialist, Phuket Island Rehab.

The signs of addiction fall into four broad categories: physical signs that family members can observe (changes in appearance, sleep, appetite, eyes, weight, and the presence of drug paraphernalia), behavioural changes (changes in social patterns, work performance, money management, secrecy, and time spent on substance-related activities), emotional and cognitive symptoms (mood swings, irritability, depression, anxiety, denial, and the obsessive focus on the substance), and social and relationship impacts (isolation, conflict with loved ones, neglect of responsibilities, and the erosion of important relationships). The DSM-5 defines substance use disorder by 11 specific criteria including taking more than intended, unsuccessful efforts to cut down, time spent obtaining and using, craving, role impairment, continued use despite problems, important activities given up, recurrent use in hazardous situations, continued use despite knowledge of consequences, tolerance, and withdrawal. Two to three criteria define mild substance use disorder, four to five moderate, and six or more severe. Recognising the signs is the first step toward seeking help, but denial is itself one of the most consistent features of addiction and can prevent the person from recognising the pattern in themselves. Family members often recognise the signs before the person does and can play a critical role in encouraging treatment.

What addiction is in clinical terms

Addiction is the lay term for what clinicians call substance use disorder, a chronic medical condition characterised by compulsive use of a substance despite harmful consequences. The DSM-5 Diagnostic and Statistical Manual of Mental Disorders defines substance use disorder for each of the major substances (alcohol use disorder, opioid use disorder, stimulant use disorder, cannabis use disorder, and so on) using a single set of 11 criteria that apply across substances with minor variations. The criteria reflect the multiple dimensions of the disorder: impaired control over use, social and occupational impairment, risky use, and pharmacological features including tolerance and withdrawal.

Substance use disorder is best understood as a brain disease that develops through repeated substance exposure interacting with biological vulnerability, social context, and individual history. The brain reward circuit, particularly the mesolimbic dopamine pathway connecting the ventral tegmental area to the nucleus accumbens, becomes progressively dysregulated through chronic substance exposure. The result is reduced response to natural rewards (food, sex, social connection, achievement) and increased response to drug-related cues, producing the compulsive pursuit of the substance that defines the disorder. The disorder is not a moral failing or a problem of willpower; it is a chronic medical condition that requires treatment.

The understanding of addiction as a chronic disease has implications for how the signs are recognised and how recovery is approached. The signs develop progressively over months to years rather than appearing suddenly. The disease has periods of remission and relapse rather than being either present or absent. The signs are often visible to family members and clinicians before the affected person recognises them, because denial is one of the consistent features of the disorder. Effective treatment exists and produces substantial improvement in most patients who engage with it, but recovery is a long-term process rather than a quick cure.

Recognising the signs of addiction is the first step toward seeking help, but it is not always sufficient on its own. Many people with substance use disorder are aware that their use has become problematic but are unable to address it without external support. Family members, friends, clinicians, and other concerned parties can play important roles in identifying the pattern, raising the concern, and supporting the person in seeking treatment. Understanding what the signs look like helps these conversations be more productive.

Physical signs of addiction

Physical signs are often the first to be noticed by family members and friends, partly because they are more visible than internal experience and partly because they are difficult for the affected person to hide. The specific physical signs depend on the substance involved, but several patterns are common across multiple substances. Changes in appearance often appear first: the person looks more aged than their chronological age, their skin becomes less healthy in appearance, their hair may become dry or thin, and they may pay less attention to grooming and personal hygiene than before.

Eye changes are characteristic of several substances and provide useful information. Opioid users typically have pinpoint pupils that do not dilate in dim light. Stimulant users have dilated pupils. Cannabis users often have red eyes from the conjunctival blood vessel dilation. Alcohol users may have bloodshot eyes, particularly in the morning after heavy drinking, and chronic alcohol users develop characteristic facial features including a reddened nose and cheeks from rosacea and broken capillaries. Hallucinogen users may have noticeably dilated pupils for hours after a trip.

Weight changes occur with most substances. Stimulant use typically produces weight loss through appetite suppression and increased metabolic activity. Opioid use can produce weight loss in the context of severe use disorder when the person stops eating properly, though it does not directly suppress appetite. Alcohol use often produces weight gain because of the calorie content of alcoholic beverages and because of the eating that accompanies drinking. Cannabis use may produce weight gain through increased appetite. Significant weight change without an obvious cause should raise consideration of possible substance use.

Sleep changes are nearly universal across substances. Stimulants disrupt sleep with reduced total sleep time, increased awakenings, and altered sleep architecture. Opioids initially produce sedation but with chronic use disrupt the sleep cycle and produce disturbed sleep. Alcohol produces sedation that fragments the second half of the night, with early-morning waking and unrefreshing sleep common in heavy drinkers. Benzodiazepines produce dependence-related sleep disturbance similar to alcohol. Cannabis affects REM sleep with possible vivid dreams during withdrawal. The complaint of sleep difficulty in a person whose previous sleep was normal is one of the more useful signs of possible substance use.

Other physical signs include changes in muscle and motor function (ataxia, tremor, slurred speech, slowed movements), gastrointestinal symptoms (constipation with opioids, nausea and vomiting with multiple substances, weight loss), skin changes (track marks at injection sites in intravenous users, picking sores from stimulant use, jaundice from advanced liver disease in chronic alcohol users), and respiratory changes (slowed breathing with opioids, the smell of alcohol on the breath, the smell of cannabis on clothing or in the home, the smell of methamphetamine in heavy users). The constellation of signs is more informative than any single sign.

Behavioural signs of addiction

Behavioural changes often precede or accompany the physical signs and may be the first thing that family members notice. Changes in social patterns are common: the person spends less time with previous friends, more time with new acquaintances who may be involved in substance use, and less time at family events or in the home. They may be unavailable at predictable times each day or week, which may correspond to the timing of their substance use. They may avoid social situations where their substance use would be obvious or where the substance is not available.

Changes in work or school performance often emerge. Punctuality declines, attendance becomes less reliable, performance on tasks decreases, and there may be incidents of obvious impairment at work that produce disciplinary action. Money management problems develop as the substance becomes more central to the person’s life, with rent or bills going unpaid, debts accumulating, possessions sold to fund use, and in some cases theft from family members or workplace. Financial stress may emerge as one of the more visible consequences of advancing use.

Secrecy and dishonesty become more prominent. The person hides their use from family members, lies about where they have been and what they have been doing, denies use when confronted, and may steal money or possessions to fund use. The accumulation of lies and the awareness that the relationship has become structured around them produces guilt and shame that often drive further use. The family members who confront the lies are often met with anger or defensiveness rather than honesty, which can be one of the more painful aspects of addiction for the family.

Time spent on substance-related activities increases. Hours of the day previously spent on hobbies, exercise, family time, or other activities are now spent obtaining the substance, using it, recovering from use, or thinking about the next use. The person may travel to specific locations to obtain the substance, may spend time with specific people who use with them, and may organise their schedule around use. This pattern often emerges before the person themselves recognises how much of their life has become organised around the substance.

Risk-taking behaviour increases. The person uses in physically hazardous situations including driving under the influence, operating machinery while impaired, swimming or diving while impaired, having unsafe sex, and using substances in unsafe physical environments. The judgement that would ordinarily prevent these behaviours is impaired by the substance use itself, and the person continues to take risks despite previous adverse consequences. Legal problems including DUI arrests, public intoxication, possession charges, and theft to fund use are not uncommon.

Emotional and cognitive signs

Emotional changes are real and substantial but may be less visible from the outside than physical or behavioural signs. Mood swings become prominent, with the person being irritable, anxious, or depressed when not using and apparently calm or content while using. The contrast can be striking enough that family members notice that the person’s mood is clearly different at predictable times. Depression often develops or worsens during chronic substance use, with substance-induced depression sometimes contributing to suicidal ideation that requires urgent attention. Anxiety often increases despite the apparent calming effect of some substances, with the increased anxiety driving further use in a vicious cycle.

Irritability and emotional reactivity become more pronounced. Small frustrations produce outsized responses. Conflict with family members, friends, and colleagues becomes more common. The person may be defensive about their use even when no one has confronted them, anticipating criticism and responding to it preemptively. The emotional reactivity is partly a direct effect of the substance on brain function, partly the consequence of chronic sleep disruption, and partly the manifestation of the underlying stress of maintaining the addiction.

Cognitive changes include difficulty concentrating, reduced working memory, impaired decision-making, and the obsessive focus on the substance that crowds out other thoughts. The person may seem distracted, forgetful, and unable to engage fully with conversations or tasks. They may make poor decisions that seem inexplicable to family members, often related to the substance use but extending into financial, relational, and professional choices. Long-term substance use can produce more persistent cognitive impairment that may not fully recover with abstinence.

Denial is one of the most consistent emotional and cognitive features of addiction and is one of the main reasons that the person themselves often does not recognise the signs that family members can see. The denial is not deliberate lying in most cases; it is a genuine inability to accept that the use has become problematic. The mind protects itself from the painful recognition that something so central to daily life has become harmful, and the protection takes the form of minimising, rationalising, comparing favourably to people who use more, attributing problems to external causes, and dismissing concerns raised by family. Denial is not a moral failing; it is part of the disease.

Social and relationship signs

The impact of addiction on relationships is one of the more clinically important and most personally painful aspects of the disorder. Romantic partnerships are particularly affected. Partners experience the broken promises, the dishonesty, the financial problems, the emotional unavailability, and the sense of competing with the substance for the affected person’s attention. Marriage rates are lower and divorce rates higher in people with substance use disorders. The partners who remain often develop their own characteristic responses to living with the disorder, including codependency patterns, enabling behaviours, anxiety, depression, and the recognition that their own lives have become organised around the affected person’s addiction.

Parent-child relationships suffer in both directions. Parents who have substance use disorders are less available to their children physically and emotionally, miss important events, may be impaired during childcare, and produce the unpredictable home environment that children of substance users describe. Adult children of parents with substance use disorders carry the effects throughout their lives, with elevated rates of substance use disorder, mental health conditions, and relationship problems themselves. The intergenerational transmission of addiction is one of the more consistent findings in addiction research.

Friendships change. Previous friendships often weaken as the person becomes less available, less reliable, and less able to maintain the emotional reciprocity that friendships require. New friendships form, often with other people who use the same substances, providing social context for the use but typically lacking the depth and stability of older friendships. The person’s social network gradually shifts toward substance-using peers, which in turn supports continued use and makes change more difficult. Recovery typically requires substantial change in social network alongside the change in substance use itself.

Family relationships beyond the immediate household are also affected. Siblings, parents of adult children with substance use disorders, and extended family members all experience the consequences of the person’s use through missed events, broken promises, financial requests, and the witnessing of the disease progression. Many families have a member with substance use disorder and have developed their own patterns of response, some of which support recovery and some of which inadvertently enable continued use. Family education through Al-Anon, Nar-Anon, and similar programs helps family members support recovery effectively while protecting their own wellbeing.

The DSM-5 criteria: how clinicians diagnose substance use disorder

The DSM-5 criteria for substance use disorder provide the standard framework for clinical diagnosis. The 11 criteria are organised into four groups: impaired control over use (4 criteria), social impairment (3 criteria), risky use (2 criteria), and pharmacological criteria (2 criteria). The criteria are applied to use over the past 12 months. Two to three criteria meet the threshold for mild substance use disorder, four to five define moderate, and six or more define severe.

The impaired control criteria include: taking the substance in larger amounts or for longer than intended; persistent desire or unsuccessful efforts to cut down or control use; spending a great deal of time obtaining, using, or recovering from the substance; and craving or strong desire to use the substance. These four criteria reflect the loss of voluntary control over use that is central to the addiction concept. The person who consistently meets these criteria has crossed from voluntary use to use that operates outside of their conscious decision-making.

The social impairment criteria include: failure to fulfill major role obligations at work, school, or home because of use; continued use despite persistent or recurrent social or interpersonal problems caused or exacerbated by the substance; and giving up or reducing important social, occupational, or recreational activities because of use. These criteria capture the way that addiction encroaches on the rest of life and crowds out the relationships, work, and activities that previously gave the person meaning and structure.

The risky use criteria include: recurrent use in physically hazardous situations; and continued use despite knowledge of having a persistent or recurrent physical or psychological problem likely caused or exacerbated by the substance. These criteria capture the failure of normal risk-avoidance and the persistence of use despite recognised harm, which together distinguish addiction from ordinary substance use even at heavy levels.

The pharmacological criteria include tolerance and withdrawal. Tolerance is defined as a need for markedly increased amounts of the substance to achieve intoxication or the desired effect, or markedly diminished effect with continued use of the same amount. Withdrawal is the characteristic syndrome for the substance, or the use of the substance (or a closely related one) to relieve or avoid withdrawal symptoms. These pharmacological features are physiological adaptations and are not present in all substance use disorders, particularly those involving substances that do not produce typical tolerance and withdrawal.

Signs that vary by substance

While the general patterns of addiction are similar across substances, several specific signs are characteristic of particular substances and warrant individual attention. Alcohol use disorder, which is the clinical term for what most people call alcoholism, often produces the smell of alcohol on the breath, slurred speech and ataxia during intoxication, the gastrointestinal effects of chronic drinking including reflux and gastritis, the cardiovascular effects of chronic drinking including hypertension and cardiomyopathy, and the neurological effects including peripheral neuropathy and Wernicke-Korsakoff syndrome in severe cases.

Opioid use disorder produces the characteristic eye signs (pinpoint pupils during use, dilated pupils during withdrawal), the sedation and nodding off characteristic of intoxication, constipation, weight loss in advanced cases, track marks at injection sites, and the severe withdrawal syndrome including muscle aches, anxiety, sweating, and gastrointestinal symptoms. Counterfeit pills sold via social media frequently contain fentanyl, making any use of pills outside legitimate prescription substantially more dangerous.

Stimulant use disorder, including cocaine, methamphetamine, and prescription stimulant misuse, produces the characteristic agitation and increased energy during intoxication, dilated pupils, decreased appetite and weight loss, dental problems (particularly with methamphetamine, sometimes called meth mouth), skin picking and sores from compulsive picking, paranoia and sometimes frank psychosis at high doses, and the post-use crash with severe fatigue and depression. Cardiovascular complications including heart attack and stroke at young ages are a particular concern.

Cannabis use disorder is recognised in the DSM-5 and produces signs including red eyes, dry mouth, the smell of cannabis on clothing and in environments where use occurs, slowed reaction time and impaired coordination during use, motivation reduction with chronic heavy use, and the subtle but real cognitive impairment that develops with chronic adolescent use. The risk of precipitating psychotic illness in vulnerable individuals is a particular concern. Modern high-potency cannabis products including dabs and concentrates produce more severe effects than the cannabis of previous decades.

Benzodiazepine use disorder often develops from prescribed medication that becomes problematic over months to years. Signs include the cognitive impairment and slowed reaction time of chronic use, falls and fractures particularly in older adults, the rebound anxiety and insomnia between doses, and the difficulty stopping despite recognising the problem. Counterfeit benzodiazepine pills sold via social media frequently contain fentanyl, similar to counterfeit opioids.

When alcohol use disorder is the most common pattern

Alcohol use disorder is the most common substance use disorder in most countries and accounts for the largest fraction of substance-related medical and social harm globally. The DSM-5 criteria for alcohol use disorder are the same general framework, with two to three criteria defining mild, four to five moderate, and six or more severe. Many people who drink heavily meet criteria for at least mild alcohol use disorder without recognising the pattern, partly because alcohol use is socially normalised in most cultures.

Specific signs of alcohol use disorder include drinking more than intended in social settings, drinking earlier in the day than was previously the pattern, drinking alone or in secret, drinking through hangovers, morning drinking to manage withdrawal symptoms, the development of tolerance requiring more alcohol to produce the desired effect, withdrawal symptoms when not drinking including tremor, sweating, anxiety, and in severe cases seizures or delirium tremens, and the social, occupational, and medical problems that accumulate over years of heavy use.

Treatment of alcohol use disorder is highly effective when patients engage with it. Medical detoxification under supervision is needed for moderate to severe cases because alcohol withdrawal can be life-threatening. Medications including naltrexone, acamprosate, and disulfiram are available for ongoing treatment. Behavioural approaches including cognitive behavioural therapy, motivational interviewing, and 12-step facilitation produce good outcomes. Residential treatment is appropriate for severe cases or for patients who have not responded to outpatient care. Phuket Island Rehab provides residential addiction medicine treatment for international patients with alcohol use disorder.

What to do if you recognise the signs

Recognising the signs of addiction is the first step but is not sufficient on its own. If you recognise the signs in yourself, the most useful next step is to talk to someone you trust about what you have noticed. A primary care physician, a mental health professional, a trusted friend or family member, or a support group can provide the support and the perspective that often helps move from recognition to action. The SAMHSA helpline in the United States provides free confidential information and referral and is available 24 hours.

If you recognise the signs in a loved one, the response requires care. Confrontational approaches based on accusation often produce defensiveness and resistance rather than recognition. The more effective approach involves expressing specific concerns about specific observations without judgement, offering support, and encouraging professional assessment. The CRAFT model (Community Reinforcement and Family Training) developed by Robert Meyers and colleagues provides a structured approach for family members to encourage treatment engagement that has good empirical support.

Professional assessment provides the most useful initial step in most cases. A primary care physician can do an initial screening and refer to addiction medicine specialists as needed. Addiction medicine specialists, addiction psychiatrists, and licensed addiction counsellors can provide formal assessment and treatment recommendations. Many primary care practices now have integrated behavioural health services that can address substance use concerns in the context of overall medical care.

Treatment options span a spectrum from outpatient counselling to intensive outpatient programs to residential treatment, with medication-assisted treatment available for alcohol, opioid, and tobacco use disorders. The treatment matched to the severity of the disorder produces the best outcomes. Mild substance use disorder may respond to outpatient counselling or 12-step participation alone. Moderate disease often benefits from intensive outpatient treatment or partial hospitalisation. Severe disease usually requires residential treatment as the initial intervention, with extended outpatient care and recovery activities to support long-term recovery.

Summary

The signs of addiction fall into four broad categories: physical signs (changes in appearance, weight, sleep, eyes, and the presence of paraphernalia), behavioural changes (changes in social patterns, work performance, secrecy, and substance-related time), emotional and cognitive symptoms (mood swings, irritability, denial, and obsessive focus on the substance), and social and relationship impacts (isolation, conflict, and erosion of important relationships). The DSM-5 defines substance use disorder by 11 specific criteria covering impaired control, social impairment, risky use, and pharmacological features, with two to three criteria defining mild, four to five moderate, and six or more severe. Family members often recognise the signs before the affected person does, because denial is a consistent feature of the disorder. Recognising the signs is the first step toward seeking help, with treatment available through outpatient counselling, intensive programs, residential rehab, and medication-assisted treatment depending on severity. As Dr. Ponlawat Pitsuwan summarises, “The signs of addiction are usually visible to family members long before the person themselves can see them, and the family conversation about what has been observed is often the inflection point that opens the path to treatment. The signs are not failures of character but symptoms of a treatable disease, and recognising them is the beginning rather than the end of the work.”

Frequently asked questions

What are the early signs of addiction?

Early signs include using more or for longer than intended, unsuccessful attempts to cut down, increasing tolerance requiring more of the substance for the same effect, organising more of daily life around use, secrecy about use, mild withdrawal symptoms between uses, changes in mood and energy when not using, and the beginning of the pattern of continued use despite minor problems. Early signs are often subtle and may be visible to family members before the person themselves recognises them.

What are the physical signs of addiction?

Physical signs depend on the substance but often include changes in appearance (looking older than chronological age, poor grooming, weight changes), eye changes (pinpoint pupils with opioids, dilated pupils with stimulants, red eyes with cannabis), sleep disruption, changes in skin (track marks with injection drug use, sores from picking with stimulants), and the smell of substances on breath or clothing. Specific substances produce specific physical signs that family members may recognise.

How do you know if someone is addicted?

Addiction is suggested by the pattern of use continuing despite harm, the loss of voluntary control over use, the impact on relationships and work, and the physical or behavioural changes that family members can observe. Formal diagnosis uses the DSM-5 criteria of substance use disorder, with two to three criteria defining mild, four to five moderate, and six or more severe. Professional assessment by a physician, addiction medicine specialist, or licensed counsellor provides the clearest picture.

What is the difference between addiction and dependence?

Physical dependence is the body’s adaptation to a substance, producing withdrawal symptoms when use stops. Addiction (substance use disorder) is the broader pattern that includes physical dependence plus loss of voluntary control over use, continued use despite harm, and other features. A patient on chronic opioid therapy for pain may have physical dependence without having addiction; a person who uses cocaine compulsively despite consequences may have addiction without classical physical dependence. The DSM-5 substance use disorder category captures both elements.

Can someone be addicted and not know it?

Yes. Denial is one of the most consistent features of addiction. The mind protects itself from the painful recognition that something central to daily life has become harmful, taking the form of minimising, rationalising, comparing favourably to people who use more, attributing problems to external causes, and dismissing concerns raised by family. Many people with substance use disorder have a clearer view of others’ substance use than their own, and may not recognise the pattern in themselves until something forces a re-evaluation.

How do you help someone with addiction?

Effective approaches include expressing specific concerns about specific observations without judgement, offering support, encouraging professional assessment, and using approaches like the CRAFT model (Community Reinforcement and Family Training) that have empirical support for family-led engagement. Avoid confrontational accusations that often produce defensiveness. Avoid enabling behaviours that protect the person from the consequences of their use. Family education through Al-Anon, Nar-Anon, and similar programs helps family members support recovery while protecting their own wellbeing.

Sources

• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Arlington, VA: American Psychiatric Publishing; 2013.
• National Institute on Drug Abuse (NIDA). Drugs, Brains, and Behavior: The Science of Addiction. https://nida.nih.gov/publications/drugs-brains-behavior-science-addiction
• Volkow ND, Koob GF, McLellan AT. Neurobiologic advances from the brain disease model of addiction. New England Journal of Medicine. 2016;374(4):363-371. https://www.nejm.org/doi/full/10.1056/NEJMra1511480
• Substance Abuse and Mental Health Services Administration (SAMHSA). National Helpline. https://www.samhsa.gov/find-help/national-helpline
• Smith JE, Meyers RJ. Motivating Substance Abusers to Enter Treatment: Working with Family Members. Guilford Press; 2004.
• National Institute on Alcohol Abuse and Alcoholism (NIAAA). Alcohol Use Disorder. https://www.niaaa.nih.gov/alcohols-effects-health/alcohol-use-disorder
• American Society of Addiction Medicine (ASAM). Definition of Addiction. https://www.asam.org/quality-care/definition-of-addiction

Addiction, substance use disorder, SUD, DSM-5, alcohol use disorder, AUD, opioid use disorder, OUD, stimulant use disorder, cannabis use disorder, benzodiazepine use disorder, hallucinogen use disorder, tolerance, physical dependence, withdrawal, craving, loss of control, denial, impaired control, social impairment, risky use, pharmacological criteria, mild substance use disorder, moderate substance use disorder, severe substance use disorder, brain reward circuit, mesolimbic dopamine pathway, ventral tegmental area, nucleus accumbens, alcohol, opioids, heroin, oxycodone, hydrocodone, fentanyl, methadone, buprenorphine, cocaine, methamphetamine, crystal meth, Adderall, Vyvanse, Ritalin, cannabis, marijuana, dabs, concentrates, benzodiazepines, Xanax, Ativan, Klonopin, Valium, hallucinogens, LSD, psilocybin, mushrooms, MDMA, ketamine, pinpoint pupils, dilated pupils, red eyes, track marks, meth mouth, intervention, CRAFT, Community Reinforcement and Family Training, motivational interviewing, cognitive behavioural therapy, CBT, 12-step program, Alcoholics Anonymous, AA, Narcotics Anonymous, NA, Al-Anon, Nar-Anon, codependency, enabling, naltrexone, Vivitrol, acamprosate, disulfiram, medication-assisted treatment, MAT, residential rehab, intensive outpatient program, IOP, partial hospitalisation, NIDA, NIAAA, SAMHSA, NHS, American Society of Addiction Medicine, ASAM, Phuket Island Rehab, addiction medicine, mental health treatment, dual diagnosis, depression, anxiety, post-traumatic stress disorder, PTSD.